GlycoMimetics Correlations

GLYC Stock

USD 0.35 0.04 12.90%

The current 90-days correlation between GlycoMimetics and Lyra Therapeutics is 0.19 (i.e., Average diversification). The correlation of GlycoMimetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

GlycoMimetics Correlation With Market

Good diversification

The correlation between GlycoMimetics and DJI is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding GlycoMimetics and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlycoMimetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For information on how to trade GlycoMimetics Stock refer to our How to Trade GlycoMimetics Stock guide.

Moving together with GlycoMimetics Stock

0.63	VCYT	Veracyte	Pair Corr
0.66	VERA	Vera Therapeutics	Pair Corr
0.72	DRUG	Bright Minds Biosciences Trending	Pair Corr
0.73	SABSW	SAB Biotherapeutics	Pair Corr
0.82	DVAX	Dynavax Technologies	Pair Corr
0.71	VRNA	Verona Pharma PLC	Pair Corr
0.81	VSTM	Verastem Trending	Pair Corr

Moving against GlycoMimetics Stock

0.71	ME	23Andme Holding Upward Rally	Pair Corr
0.65	DOMH	Dominari Holdings	Pair Corr
0.59	A	Agilent Technologies Sell-off Trend	Pair Corr
0.58	DRMA	Dermata Therapeutics	Pair Corr
0.57	VALN	Valneva SE ADR	Pair Corr
0.44	DRRX	Durect	Pair Corr
0.76	VIRX	Viracta Therapeutics	Pair Corr
0.66	DTIL	Precision BioSciences	Pair Corr
0.66	VINC	Vincerx Pharma	Pair Corr
0.63	VRCA	Verrica Pharmaceuticals	Pair Corr
0.53	CDTTW	Conduit Pharmaceuticals	Pair Corr
0.38	VTGN	VistaGen Therapeutics	Pair Corr

Related Correlations Analysis

	MIST	MCRB	DMAC	LYRA	CNTA	KTTA
MIST		-0.29	0.36	-0.49	0.7	-0.62	MIST
MCRB	-0.29		0.07	0.39	-0.14	0.31	MCRB
DMAC	0.36	0.07		-0.4	0.52	-0.29	DMAC
LYRA	-0.49	0.39	-0.4		-0.67	0.39	LYRA
CNTA	0.7	-0.14	0.52	-0.67		-0.41	CNTA
KTTA	-0.62	0.31	-0.29	0.39	-0.41		KTTA
	MIST	MCRB	DMAC	LYRA	CNTA	KTTA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CNTA	+ 0.7	MIST
CNTA	+ 0.52	DMAC
LYRA	+ 0.39	MCRB
KTTA	+ 0.39	LYRA
DMAC	+ 0.36	MIST
KTTA	+ 0.31	MCRB

High negative correlations

CNTA	- 0.67	LYRA
KTTA	- 0.62	MIST
LYRA	- 0.49	MIST
KTTA	- 0.41	CNTA
LYRA	- 0.4	DMAC
KTTA	- 0.29	DMAC

Risk-Adjusted Indicators

There is a big difference between GlycoMimetics Stock performing well and GlycoMimetics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze GlycoMimetics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MIST	1.94	0.31	0.18	0.33	1.54	(2.90)	7.19	(2.11)	18.66
MCRB	4.99	0.45	0.06	1.50	5.62	(5.99)	10.84	(9.78)	28.84
DMAC	2.61	0.57	0.19	6.99	1.94	(3.23)	6.41	(3.29)	14.14
LYRA	4.22	(0.60)	0.00	(0.31)	0.00	0.00	10.53	(10.00)	41.07
CNTA	2.81	0.36	0.10	0.45	3.08	(3.14)	8.37	(5.69)	21.09
KTTA	5.25	(0.30)	0.00	(0.42)	0.00	0.00	8.27	(11.00)	68.44

GlycoMimetics Corporate Executives

Elected by the shareholders, the GlycoMimetics' board of directors comprises two types of representatives: GlycoMimetics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GlycoMimetics. The board's role is to monitor GlycoMimetics' management team and ensure that shareholders' interests are well served. GlycoMimetics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GlycoMimetics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Brian Hahn

CFO and Principal Accounting Officer

Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC